QNRX Stock Analysis: Buy, Sell, or Hold?

QNRX - Quoin Pharmaceuticals, Ltd. American Depositary Shares

PHARMACEUTICAL PREPARATIONS
$7.22
-1.09 (-13.07%) ▼
WAIT
LOW Confidence
Protect Your QNRX Gains
Last Updated: January 30, 2026
Earnings: Mar 12, 2026

Get Alerted When QNRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: QNRX is down 24.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: QNRX is currently trading at $7.21, which is considered oversold relative to its 30-day fair value range of $9.60 to $13.88.

Technical Outlook: Technically, QNRX is in a uptrend. The price is currently testing key support at $8.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 13.1% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.67 (+390.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $9.60 - $13.88
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Protect Your Profits

Holding QNRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-13.1%)
  • BULLISH: Trading 390.0% below Wall St target ($40.67)
  • WARNING: Recommendation downgraded due to -24.8% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $9.60 - $13.88
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $8.20
Resistance Level $10.95
Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -1.50
Wall Street Target $40.67 (+390.0%)
Last updated: January 30, 2026 7:35 PM ET
Data refreshes hourly during market hours. Next update: 8:35 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Dennis Langer BUY 15152 shares 2025-10-14

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$404 63 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$56 59 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$210 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$8 53 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$85 55 HOLD

Advanced QNRX Option Strategies

Professional options setups generated by AI based on today's QNRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for QNRX

QNRX Technical Chart QNRX Price Prediction QNRX Earnings Date QNRX Investment Advisor QNRX Fair Price Analyzer QNRX Options Advisor QNRX Options Chain QNRX Options Analysis QNRX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals